Sign in
4

Changes in Ownership

Arcturus Therapeutics Holdings Inc. Filed Acc 0001193805-23-001002

See Remarks sold 6,968 shares at $35.00 ($243,880)

  • See Remarks acquired 6,968 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kummerfeld Keith C See Remarks 2023-07-14 Option exercise +4,500 $9.04 $40,680 5,450 D: show line 1 in the form
Kummerfeld Keith C See Remarks 2023-07-14 Option exercise +1,437 $4.99 $7,171 6,887 D: show line 2 in the form
Kummerfeld Keith C See Remarks 2023-07-14 Option exercise +1,031 $14.12 $14,558 7,918 D: show line 3 in the form
Kummerfeld Keith C See Remarks 2023-07-14 Sale −6,968 $35.00 $243,880 950 D: show line 4 in the form
Open-market sales · 6,968 sh · avg $35.00 · $243,880

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kummerfeld Keith C See Remarks 2023-07-14 Option exercise · Employee Stock Option (right to buy) −4,500 21,000 D: show line 5 in the form
Kummerfeld Keith C See Remarks 2023-07-14 Option exercise · Employee Stock Option (right to buy) −1,437 7,126 D: show line 6 in the form
Kummerfeld Keith C See Remarks 2023-07-14 Option exercise · Employee Stock Option (right to buy) −1,031 7,938 D: show line 7 in the form
Loading xslF345X05/e618788_4-kummerfeld.xml…